Spectrum Pharmaceuticals (SPPI) Stock Rockets On Positive Cancer Data
Spectrum Pharmaceuticals, Inc. (NASDAQ: SPPI) is running for the top in the market this morning, and for good reason. The company announced positive data from a Phase 2 clinical trial assessing a cancer therapy. Here’s what’s going on: Stop wasting your time! Start finding winning trades in minutes with Trade Ideas! SPPI Rockets On Positive … Read more